Soligenix SNGX
NASDAQ SNGX
$0.37 +0.02 (+6.98%)
As of: Oct 22, 2026 · 10:22 AM EDT

Soligenix (SNGX) Receivables (2010 - 2011)

Updated

Soligenix (SNGX) reported Receivables of $297,847 for Q3 2011, down 12.6% from the prior quarter.

Analysis

Soligenix (SNGX) Receivables (2010 - 2011) Analysis & Trends

At the end of FY2010, Soligenix posted Receivables of $372,651.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,167.17 Bn 1,135.76 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 633.70 Bn 552.23 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.94 Bn 477.06 Bn 12.70 Bn 13.82 Bn
4 Merck 378.10 Bn 332.47 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 303.72 Bn 267.71 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 266.46 Bn 240.15 Bn 12.86 Bn 15.68 Bn
7 Amgen 241.07 Bn 196.47 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.22 Bn 168.41 Bn 6.22 Bn 5.06 Bn
9 Pfizer 172.39 Bn 119.04 Bn 10.94 Bn 12.49 Bn
10 Soligenix 5.75 Mn -28.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 297,847.00
Jun 30, 2011 340,882.00
Dec 31, 2010 372,651.00
API Access

Soligenix Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=SNGX&period=max&api_key=YOUR_API_KEY